CClinicalTrials.gg
CompletedNCT02781675MFFDUpdated Aug 2, 2019

The Mediterranean Full-Fat Dairy Study

An interventional study of Dietary Intervention in Cardiovascular Disease, Dyslipidemia and Inflammation, sponsored by UCSF Benioff Children's Hospital Oakland. Completed at 1 site in United States. Open to participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-08-02.

Sponsored by UCSF Benioff Children's Hospital Oakland · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
21 Years and older
Sex
All
01

Study summary

A Mediterranean dietary pattern emphasizing an abundance of plant-based foods including nuts, moderate intakes of fish, poultry and low-fat dairy products, and use of extra virgin olive oil as the main source of fat has been associated with reduced risk of cardiovascular disease (CVD), and such a pattern has been advocated by the 2015 U.S. Dietary Guidelines Advisory Committee. The strongest experimental support for this recommendation derives from the success of the recent PREDIMED CVD outcomes trial, and studies indicating that a Mediterranean-style diet improves lipoprotein and oxidative markers of cardiovascular disease risk in comparison to either low-fat or Western dietary patterns. However, in none of these studies were comparisons made between the effects of Mediterranean-style diets with low-/nonfat vs. full-fat dairy foods. The overall objective of the present proposal is to determine whether the inclusion of full-fat rather than low- and nonfat dairy foods in a Mediterranean dietary pattern based on that used in the PREDIMED study results in similar improvements in biomarkers of CVD risk. Specifically, we will test the hypotheses that 1) a standard Mediterranean diet will lower LDL-C and apoB compared to a Western diet; 2) modification of the Mediterranean diet by replacing low-fat dairy products with high-fat dairy (3 servings/day; high-dairy fat Mediterranean diet) will not significantly increase LDL-C and apoB but may raise large buoyant LDL particles compared with a standard Mediterranean diet; and 3) the high dairy fat and standard Mediterranean diets will result in comparable reductions in levels of inflammatory markers and oxidized LDL, and improvements in endothelial function compared to a Western diet.

02

Conditions studied

  • Cardiovascular Disease
  • Dyslipidemia
  • Inflammation

Keywords

  • Diet
  • Mediterranean
  • Cholesterol
  • Inflammation
03

In context

Cardiovascular Diseases

4,904 studies on the registry are indexed under Cardiovascular Diseases; 919 are open to participants now.

This study's enrollment of 40 is below the median of 100 across 2,738 interventional studies indexed under Cardiovascular Diseases.

Browse Cardiovascular Diseases studies →

Lead sponsor

UCSF Benioff Children's Hospital Oakland is the lead sponsor of 53 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • BMI 25-35 kg/m2
  • Weight stable for > 3 months
  • Agrees to abstain from alcohol or dietary supplements during the study

Exclusion criteria

Exclusion Criteria:

  • History of coronary heart disease, cerebrovascular disease, peripheral vascular disease, bleeding disorder, liver or renal disease, diabetes, lung disease, HIV, or cancer (other than skin cancer) in the last 5 years.
  • Current use of hormones or drugs knowns to affect lipid metabolism
  • Use of nicotine products or recreational drugs
  • Abnormal TSH
  • Pregnant or breastfeeding
  • Total- and LDL- cholesterol > 95th percentile for sex and age
  • Fasting triglyceride > 500 mg/dl
  • Fasting blood sugar > 126 mg/dl
  • Blood pressure >160/95 mm Hg
  • Allergy to or unwillingness to consume study foods
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Western Diet

    Dietary Intervention: 3 wks of a typical Western Diet

    Other: Dietary Intervention

  • Experimental
    Mediterranean Diet

    Dietary Intervention: 3 wks of a Mediterranean-style diet

    Other: Dietary Intervention

  • Experimental
    Modified Mediterranean Diet

    Dietary Intervention: 3 wks of a Mediterranean-style diet including full fat dairy products

    Other: Dietary Intervention

Interventions

  • OtherDietary Intervention

    3 wk dietary intervention with prescribed menus and \~50% foods provided.

06

What researchers measure

Primary outcomes

  1. Plasma LDL-cholesterol

    Time frame: 3 weeks

  2. Plasma Apolipoprotein B

    Time frame: 3 weeks

  3. Plasma Small LDL concentrations

    Time frame: 3 weeks

  4. Plasma Large LDL particle concentrations

    Time frame: 3 weeks

  5. Plasma Total LDL particle concentrations

    Time frame: 3 weeks

Secondary outcomes

  1. Plasma triglycerides

    Time frame: 3 weeks

  2. Plasma HDL-cholesterol

    Time frame: 3 weeks

  3. Plasma apolipoprotein AI

    Time frame: 3 weeks

  4. Plasma oxidized LDL

    Time frame: 3 weeks

  5. Plasma C-reactive protein

    Time frame: 3 weeks

  6. Plasma Interleukin-6

    Time frame: 3 weeks

  7. Plasma Intercellular Adhesion Molecule 1 (ICAM-1)

    Time frame: 3 weeks

  8. Plasma Vascular Cell Adhesion Molecule 1 (VCAM-1)

    Time frame: 3 weeks

  9. RH-PAT index (endothelial function)

    Endothelial function measured by finger reactive hyperemia peripheral arterial tonography

    Time frame: 3 weeks

07

Study locations

1 site
  • Cholesterol Research Center
    Berkeley, California 94705, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 2, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02781675
Lead sponsor
UCSF Benioff Children's Hospital Oakland
Collaborators
Dairy Management Inc.
Responsible party
Sponsor
First posted
May 24, 2016
Start date
May 2016
Primary completion
Jun 2018
Completion
Jun 2018
Last update
Aug 2, 2019

Study contacts

Ronald M Krauss, MD
principal investigator · UCSF Benioff Children's Hospital Oakland

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion